Vladimir Aladinskiy

机构：Insilicos (United States), INSEAD, Insilico Medicine (United States) · ORCID：0000-0002-3976-3991

发表论文 47 篇 · 总被引 3958 次 · h-index 17

代表论文

• AlphaFold accelerates artificial intelligence powered drug discovery: efficient discovery of a novel CDK20 small molecule inhibitor (2023 · Chemical Science · 被引 341)
• A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models (2024 · Nature Biotechnology · 被引 295)
• Chemistry42: An AI-Driven Platform for Molecular Design and Optimization (2023 · Journal of Chemical Information and Modeling · 被引 208)
• Molecular Sets (MOSES): A Benchmarking Platform for Molecular Generation Models (2020 · Frontiers in Pharmacology · 被引 85)
• Potential Non-Covalent SARS-CoV-2 3C-like Protease Inhibitors Designed Using Generative Deep Learning Approaches and Reviewed by Human Medicinal Chemist in Virtual Reality (2020 · ChemRxiv · 被引 44)
• Potential Non-Covalent SARS-CoV-2 3C-like Protease Inhibitors Designed Using Generative Deep Learning Approaches and Reviewed by Human Medicinal Chemist in Virtual Reality (2020 · ChemRxiv · 被引 29)